Role of Respiratory Rate Derived From Capnography in Sedated Patients

Sponsor
Al Jedaani Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05793658
Collaborator
(none)
74
1
2
2.9
25.9

Study Details

Study Description

Brief Summary

Although appropriate sedation is recommended during colonoscopy, patients are at risk for adverse events e.g hypoventilation and hypoxemia due to inadvertent oversedation. The aim of this study was to evaluate the benefit of additional quantitative capnography monitoring ( respiratory rate )in management of patient undergoing colonoscopy under sedation in preventing or reducing the incidence of adverse events and also determine when to start the procedure and when to give and not to give increments of sedative drugs during the procedure.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Standard capnography
  • Procedure: Modified capnography
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
74 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Is Respiratory Rate Derived From Capnography Can Prevent Adverse Events Occurred in Sedated Patients.
Actual Study Start Date :
Nov 25, 2022
Actual Primary Completion Date :
Feb 20, 2023
Actual Study Completion Date :
Feb 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Sedation with standard capnography

37 patient Sedation using midazolam + propofol for colonoscopy

Procedure: Standard capnography
Patients undergoing colonoscopy under sedation were randomly assigned to receive standard capnography monitoring or modified capnography monitoring which can be achieved by tucking capnography probe under the face mask.74 patients were enrolled. Patient characteristics were well balanced between the two groups 37 patients in each group.
Other Names:
  • Qualitative capnograpyhy
  • Active Comparator: Sedation with modified capnography

    37 patients in Sedation using midazolam + fentanyl + propofol for colonoscopy

    Procedure: Modified capnography
    If Respiratory rate below 14 b/m: more sedation isn't not advised and the patient may develop airway obstruction and needs airway intervention ( like jaw thrust or oral airway) If respiratory rate more than 20 b/m it means this patient is prone to awake or to move and this patient in need for incremental dose of sedative drug ( e.g 20 to 30 mg propofol) Also roughly speaking respiratory rate from 16 to 18 b/m is the target
    Other Names:
  • Quantitative capnography
  • Outcome Measures

    Primary Outcome Measures

    1. Hypoxemia [1 hours]

      Detected by pulse oximeter

    Secondary Outcome Measures

    1. Patient movements during the procedure [1 hour]

      Measured by questionnaire to the gastroenterologist (scale from 1 to 5)

    2. Effort exerted by the anesthesiologist ( the provider) [1 hour]

      Measured by questionnaire ( scale from 1 to 5 )

    3. Patient satisfaction [1 hour]

      Measured by questionnaire ( scale from 1 to 5 )

    4. Gastroenterologist satisfaction [1 hour]

      Measured by questionnaire ( scale from 1 to 5 )

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • ASA 1 and 2 adult patients

    • Age from 20 to 50 years old

    • elective colonoscopy

    Exclusion Criteria:
    • American Society of Anesthesiologists (ASA) above Class II

    • History of psychiatric or neurological disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Al Jedaani group of hospitals Jeddah Meccah Saudi Arabia 21462/7500

    Sponsors and Collaborators

    • Al Jedaani Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Al Jedaani Hospital
    ClinicalTrials.gov Identifier:
    NCT05793658
    Other Study ID Numbers:
    • 1/5/22
    First Posted:
    Mar 31, 2023
    Last Update Posted:
    Mar 31, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Al Jedaani Hospital

    Study Results

    No Results Posted as of Mar 31, 2023